Course of IgE to α‐Gal in a Swedish population of α‐Gal syndrome patients

Of five patients who did not report tick bites, three had at least a three-fold decrease in α-Gal IgE levels (No. 38, No. 41, and No. 46). [...]one of them had not experienced symptoms after the diagnosis (No. 38). [...]AGS patients with severe reactions should strictly be avoiding α-Gal containing...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and translational allergy Vol. 11; no. 10; pp. e12087 - n/a
Main Authors: Apostolovic, Danijela, Grundström, Jeanette, Perusko, Marija, Kiewiet, M. B. Gea, Hamsten, Carl, Starkhammar, Maria, Hage, Marianne
Format: Journal Article
Language:English
Published: England John Wiley & Sons, Inc 01-12-2021
John Wiley and Sons Inc
Wiley
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Of five patients who did not report tick bites, three had at least a three-fold decrease in α-Gal IgE levels (No. 38, No. 41, and No. 46). [...]one of them had not experienced symptoms after the diagnosis (No. 38). [...]AGS patients with severe reactions should strictly be avoiding α-Gal containing food as well as tick bites. ACKNOWLEDGEMENTS The Swedish Research Council (grant number 2014-03274, 2019-01060), Region Stockholm (ALF-project), The Swedish Heart-Lung Foundation (Hjärt-Lungfonden), The Swedish Asthma and Allergy Association's Research Foundation (Astma- och Allergiförbundet), The King Gustaf V 80th Birthday Foundation, The Hesselman Foundation, The Swedish Cancer and Allergy Foundation (Insamlingsstiftelsen Cancer- och Allergifonden), EU H2020 project FoodEnTwin (GA 810752), Konsul Th C Bergh Stiftelse, Tore Nilsons Stiftelse för Medicinsk Forskning, Magnus Bergvalls Stiftelse, Eva och Oscar Ahréns Stiftelse, Svenska Läkaresällskapet and Karolinska Institutet Research Foundation grant.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2045-7022
2045-7022
DOI:10.1002/clt2.12087